Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence

The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide threat and the major healthcare concern of the year 2020. Cancer research was directly affected by the emerging of this disease. According to some Chinese studies, cancer patients are more vulnerable to COVID-19 compl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical reviews in oncology/hematology Jg. 150; S. 102972
Hauptverfasser: Moujaess, Elissar, Kourie, Hampig Raphael, Ghosn, Marwan
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Netherlands Elsevier B.V 01.06.2020
Schlagworte:
Adult
Antineoplastic Agents - therapeutic use
Betacoronavirus
Cancer patients
Clinical Laboratory Techniques
Coronavirus Infections - complications
Coronavirus Infections - diagnosis
Coronavirus Infections - drug therapy
Coronavirus Infections - therapy
COVID-19
COVID-19 Drug Treatment
COVID-19 Testing
Humans
Immunocompromised Host
Neoplasms - complications
Neoplasms - therapy
Oncology
Pandemics
Pneumonia, Viral - complications
Pneumonia, Viral - diagnosis
Pneumonia, Viral - therapy
SARS-CoV-2
Systematic review
COVID-19
Systematic review
Oncology
Cancer patients
Research
ISSN:1040-8428, 1879-0461, 1879-0461
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide threat and the major healthcare concern of the year 2020. Cancer research was directly affected by the emerging of this disease. According to some Chinese studies, cancer patients are more vulnerable to COVID-19 complications. This observation led many oncologists to change their daily practice in cancer care, without solid evidence and recommendations. Moreover, the COVID-19 manifestations as well as its diagnosis are particular in this special population. In this review paper we expose the challenges of cancer management in the era of SARS-CoV-2, the epidemiological, clinical, pathological and radiological characteristics of the disease in cancer patients and its outcomes on this population. Finally, we focus on strategies that are followed in cancer management with review of national and international guidelines.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1040-8428
1879-0461
1879-0461
DOI:10.1016/j.critrevonc.2020.102972